Insider Selling: Cooper Companies Inc (COO) Insider Sells $663,923.84 in Stock

Cooper Companies Inc (NYSE:COO) insider Robert D. Auerbach sold 2,272 shares of the stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $292.22, for a total value of $663,923.84. Following the sale, the insider now owns 2,538 shares of the company’s stock, valued at approximately $741,654.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of Cooper Companies stock opened at $295.23 on Friday. Cooper Companies Inc has a 12 month low of $216.47 and a 12 month high of $299.00. The company has a market cap of $14.58 billion, a P/E ratio of 25.67, a PEG ratio of 2.27 and a beta of 0.88. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.27 and a quick ratio of 0.75.

Cooper Companies (NYSE:COO) last announced its quarterly earnings results on Tuesday, March 5th. The medical device company reported $2.88 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.38. Cooper Companies had a return on equity of 17.56% and a net margin of 14.22%. Research analysts predict that Cooper Companies Inc will post 12.01 earnings per share for the current year.

Several large investors have recently bought and sold shares of the company. Norges Bank bought a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $117,156,000. Kentucky Retirement Systems bought a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $544,000. Kentucky Retirement Systems Insurance Trust Fund bought a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $247,000. APG Asset Management N.V. raised its holdings in shares of Cooper Companies by 1.5% in the fourth quarter. APG Asset Management N.V. now owns 6,600 shares of the medical device company’s stock worth $1,469,000 after buying an additional 100 shares during the period. Finally, Executive Wealth Management LLC purchased a new stake in shares of Cooper Companies in the fourth quarter worth approximately $34,000. 99.95% of the stock is owned by institutional investors and hedge funds.

Several analysts recently issued reports on COO shares. Jefferies Financial Group increased their target price on Cooper Companies to $330.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. KeyCorp reiterated a “buy” rating on shares of Cooper Companies in a research report on Sunday, December 9th. Zacks Investment Research upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $317.00 target price for the company in a research report on Friday, March 8th. Oppenheimer set a $282.00 target price on Cooper Companies and gave the stock a “hold” rating in a research report on Friday, December 7th. Finally, Raymond James increased their target price on Cooper Companies from $300.00 to $325.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $307.90.

TRADEMARK VIOLATION WARNING: This article was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://sportsperspectives.com/2019/03/17/insider-selling-cooper-companies-inc-coo-insider-sells-663923-84-in-stock.html.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Story: Diversification For Individual Investors

Insider Buying and Selling by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.